Daniel Gromer, MD, MSc

BIRCWH Scholar: 2026

Daniel J. Gromer, MD MSc, is a passionate physician-scientist, Assistant Professor in the Division of Infectious Diseases at Emory University School of Medicine, and Investigator at the Hope Clinic of the Emory Vaccine Center. He completed his medical degree at the University of Pennsylvania, the predoctoral Medical Research Scholars Program at the National Institutes of Health, his internal medicine residency at the Massachusetts General Hospital, and his fellowship in infectious diseases and a Master of Science in Clinical Research at Emory University. During his postdoctoral training, his work included observational studies of mpox, a clinical trial assessing a novel adenoviral-vectored human rabies vaccine, and a secondary analysis of a seasonal influenza vaccine trial.

As faculty, Dr. Gromer has continued to study globally important viral pathogens and vaccine responses. He was the Emory site principal investigator for a 510(k) study of a novel diagnostic platform for respiratory viruses and is currently co-chair of an HIV Vaccine Trials Network phase 1 trial protocol, working group member of multiple cross-institutional analyses of vaccine responses, and sub/co-investigator on numerous enrolling clinical trials. He has received multiple pilot awards from the Infectious Diseases Clinical Research Consortium (IDCRC) and an HVTN Scientific Leadership Development award to lead secondary analyses of candidate vaccine trials. Dr. Gromer also performs bone marrow aspiration procedures for the Hope Clinic’s Tissue Immunology research program, which is pioneering molecular approaches to understanding vaccine responses outside of the peripheral blood.

During these projects, Dr. Gromer developed a strong interest in the effects of sex as a biological variable (SABV) on vaccine responses and was awarded an Emory Specialized Center of Research Excellence (SCORE) pilot grant to investigate the role of SABV in ebolavirus and H7N9 pandemic influenza vaccine responses. Meanwhile, he has honed a clinical focus on people with hematologic malignancies, who are at high risk of vaccine failure due to immunosuppression from cancer and chemotherapy. These experiences have contributed to Dr. Gromer’s overall research mission, which is to understand how to better protect people with blood cancers from serious infections. As a BIRCWH K12 scholar, Dr. Gromer aims to characterize influenza vaccine responses in individuals with B cell non-Hodgkin lymphoma who have undergone chemotherapy and explore the contribution of SABV to the reconstitution of humoral immunity.

Dr. Gromer’s lead mentor is Dr. Nadine Rouphael.